Insider trading activities (stock purchases, sales, and option exercises)
reported by insiders of Labcorp Holdings Inc. (LH)
since 2015 are shown in Table 1 and Table 2.
Table 1 shows the monthly insider trading data of Labcorp Holdings Inc..
Table 2 shows the detailed insider transactions.
This company's CIK number is 920148.
Total stock buying since 2015: $1,043,003.
Total stock sales since 2015: $222,322,901.
Total stock option exercises since 2015: $77,979,648.
Table 3. Detailed insider trading at Labcorp Holdings Inc. (LH)
| Trade Date |
Insider Name |
Trade Type |
Shares |
Price ($) |
Value ($) |
| 2025-08-13 | Van Der Vaart Sandra D (EVP, Chief Legal Officer) | Sale | 3,903 | 271.43 | 1,059,371 |
| 2025-08-13 | Van Der Vaart Sandra D (EVP, Chief Legal Officer) | Option Ex | 3,903 | 131.43 | 512,971 |
| 2025-08-11 | Schechter Adam H (President & CEO) | Sale | 5,643 | 266.78 | 1,505,439 |
| 2025-07-30 | Gilliland Dwight Gary (Director) | Sale | 2,000 | 264.95 | 529,900 |
| 2025-07-29 | Wilkinson Peter J (SVP, Chief Accounting Officer) | Sale | 202 | 261.02 | 52,726 |
| 2025-07-24 | Anderson Kerrii B (Director) | Sale | 7,000 | 280.00 | 1,960,000 |
| 2025-07-01 | Anderson Kerrii B (Director) | Sale | 500 | 265.00 | 132,500 |
| 2025-06-11 | Anderson Kerrii B (Director) | Sale | 500 | 260.00 | 130,000 |
| 2025-06-03 | Caveney Brian J (EVP, Pres of ED, CMO & CSO) | Sale | 2,000 | 247.00 | 494,000 |
| 2025-05-12 | Schechter Adam H (President & CEO) | Sale | 6,105 | 248.73 | 1,518,496 |
| 2025-05-01 | Van Der Vaart Sandra D (EVP, Chief Legal Officer) | Sale | 1,900 | 238.36 | 452,884 |
| 2025-05-01 | Wilkinson Peter J (SVP, Chief Accounting Officer) | Sale | 829 | 242.26 | 200,837 |
| 2025-04-01 | Bailey Megan D. (EVP, Pres, Central Labs & Intl) | Option Ex | 4,287 | .00 | 0 |
| 2025-03-28 | Summy Amy B. (EVP, Chief Marketing Officer) | Sale | 758 | 231.67 | 175,605 |
| 2025-03-28 | Schroeder Mark S (EVP, Pres Diagnostics & COO) | Sale | 2,635 | 231.67 | 610,450 |
| 2025-03-05 | Anderson Kerrii B (Director) | Sale | 500 | 255.63 | 127,817 |
| 2025-02-28 | Schroeder Mark S (EVP, Pres Diagnostics & COO) | Sale | 5,339 | 249.23 | 1,330,638 |
| 2025-02-28 | Schroeder Mark S (EVP, Pres Diagnostics & COO) | Option Ex | 3,903 | 131.43 | 512,971 |
| 2025-02-25 | Van Der Vaart Sandra D (EVP, Chief Legal Officer) | Sale | 1,314 | 251.30 | 330,208 |
| 2025-02-24 | Summy Amy B. (EVP, Chief Marketing Officer) | Sale | 226 | 250.40 | 56,590 |
| 2025-02-18 | Wilkinson Peter J (SVP, Chief Accounting Officer) | Sale | 1,413 | 246.10 | 347,739 |
| 2025-02-18 | Wilkinson Peter J (SVP, Chief Accounting Officer) | Option Ex | 1,413 | 163.63 | 231,209 |
| 2025-02-11 | Oyegunwa Akinbolade (EVP, CIO & CTO) | Option Ex | 134 | .00 | 0 |
| 2025-02-11 | Summy Amy B. (EVP, Chief Marketing Officer) | Option Ex | 201 | .00 | 0 |
| 2025-02-11 | Schroeder Mark S (EVP, Pres Diagnostics & COO) | Option Ex | 473 | .00 | 0 |
| 2025-02-11 | Caveney Brian J (EVP, Pres of ED, CMO & CSO) | Option Ex | 473 | .00 | 0 |
| 2025-02-11 | Van Der Vaart Sandra D (EVP, Chief Legal Officer) | Option Ex | 323 | .00 | 0 |
| 2025-02-11 | Wilkinson Peter J (SVP, Chief Accounting Officer) | Option Ex | 123 | .00 | 0 |
| 2025-02-11 | Schechter Adam H (President & CEO) | Sale | 6,121 | 244.62 | 1,497,319 |
| 2025-02-11 | Schechter Adam H (President & CEO) | Option Ex | 2,963 | .00 | 0 |
| 2025-02-11 | Eisenberg Glenn A (Executive Vice President) | Option Ex | 807 | .00 | 0 |
| 2025-02-11 | Berberian Lance (EVP, Special Advisor, Strategy) | Option Ex | 323 | .00 | 0 |
| 2025-02-07 | Oyegunwa Akinbolade (EVP, CIO & CTO) | Option Ex | 149 | .00 | 0 |
| 2025-02-07 | Bailey Megan D. (EVP, Pres, Central Labs & Intl) | Option Ex | 291 | .00 | 0 |
| 2025-02-07 | Summy Amy B. (EVP, Chief Marketing Officer) | Option Ex | 224 | .00 | 0 |
| 2025-02-07 | Schroeder Mark S (EVP, Pres Diagnostics & COO) | Option Ex | 681 | .00 | 0 |
| 2025-02-07 | Caveney Brian J (EVP, Pres of ED, CMO & CSO) | Option Ex | 629 | .00 | 0 |
| 2025-02-07 | Van Der Vaart Sandra D (EVP, Chief Legal Officer) | Option Ex | 354 | .00 | 0 |
| 2025-02-07 | Wilkinson Peter J (SVP, Chief Accounting Officer) | Option Ex | 134 | .00 | 0 |
| 2025-02-07 | Schechter Adam H (President & CEO) | Option Ex | 3,250 | .00 | 0 |
| 2025-02-07 | Eisenberg Glenn A (Executive Vice President) | Option Ex | 885 | .00 | 0 |
| 2025-02-07 | Graham Anita Z (EVP, CHRO) | Option Ex | 369 | .00 | 0 |
| 2025-02-07 | Berberian Lance (EVP, Special Advisor, Strategy) | Option Ex | 354 | .00 | 0 |
| 2025-02-06 | Oyegunwa Akinbolade (EVP, CIO & CTO) | Option Ex | 180 | .00 | 0 |
| 2025-02-06 | Bailey Megan D. (EVP, Pres, Central Labs & Intl) | Option Ex | 180 | .00 | 0 |
| 2025-02-06 | Kliphouse Kirsten Marie (Director) | Option Ex | 944 | .00 | 0 |
| 2025-02-06 | Wang Julia Aijun (Chief Financial Officer, EVP) | Option Ex | 893 | .00 | 0 |
| 2025-02-06 | Summy Amy B. (EVP, Chief Marketing Officer) | Option Ex | 223 | .00 | 0 |
| 2025-02-06 | Schroeder Mark S (EVP, Pres Diagnostics & COO) | Option Ex | 743 | .00 | 0 |
| 2025-02-06 | Wengel Kathryn E (Director) | Option Ex | 944 | .00 | 0 |
| 2025-02-06 | Caveney Brian J (EVP, Pres of ED, CMO & CSO) | Option Ex | 670 | .00 | 0 |
| 2025-02-06 | Davis Jeffrey A. (Director) | Option Ex | 944 | .00 | 0 |
| 2025-02-06 | Gilliland Dwight Gary (Director) | Option Ex | 944 | .00 | 0 |
| 2025-02-06 | Rothman Paul (Director) | Option Ex | 944 | .00 | 0 |
| 2025-02-06 | Parham Richelle P (Director) | Option Ex | 944 | .00 | 0 |
| 2025-02-06 | Van Der Vaart Sandra D (EVP, Chief Legal Officer) | Option Ex | 386 | .00 | 0 |
| 2025-02-06 | Kong Garheng (Director) | Option Ex | 944 | .00 | 0 |
| 2025-02-06 | Wilkinson Peter J (SVP, Chief Accounting Officer) | Option Ex | 133 | .00 | 0 |
| 2025-02-06 | Schechter Adam H (President & CEO) | Option Ex | 4,460 | .00 | 0 |
| 2025-02-06 | Neupert Peter M (Director) | Option Ex | 944 | .00 | 0 |
| 2025-02-06 | Anderson Kerrii B (Director) | Option Ex | 944 | .00 | 0 |
| 2025-02-06 | Eisenberg Glenn A (Executive Vice President) | Option Ex | 966 | .00 | 0 |
| 2025-02-06 | Graham Anita Z (EVP, CHRO) | Option Ex | 326 | .00 | 0 |
| 2025-02-06 | Berberian Lance (EVP, Special Advisor, Strategy) | Option Ex | 356 | .00 | 0 |
| 2025-01-07 | Anderson Kerrii B (Director) | Sale | 1,000 | 235.00 | 235,000 |
| 2024-12-02 | Gilliland Dwight Gary (Director) | Sale | 1,000 | 241.00 | 241,000 |
| 2024-12-02 | Eisenberg Glenn A (Executive Vice President) | Sale | 11,711 | 240.43 | 2,815,652 |
| 2024-12-02 | Eisenberg Glenn A (Executive Vice President) | Option Ex | 11,711 | 215.46 | 2,523,252 |
| 2024-11-22 | Summy Amy B. (EVP, Chief Marketing Officer) | Sale | 3,671 | 238.91 | 877,023 |
| 2024-11-22 | Summy Amy B. (EVP, Chief Marketing Officer) | Option Ex | 4,015 | 168.52 | 676,607 |
| 2024-11-21 | Van Der Vaart Sandra D (EVP, Chief Legal Officer) | Sale | 1,000 | 239.42 | 239,419 |
| 2024-11-11 | Schechter Adam H (President & CEO) | Sale | 6,189 | 243.47 | 1,506,835 |
| 2024-10-24 | Anderson Kerrii B (Director) | Sale | 1,000 | 230.00 | 230,000 |
| 2024-08-19 | Van Der Vaart Sandra D (EVP, Chief Legal Officer) | Sale | 2,000 | 227.05 | 454,100 |
| 2024-08-15 | Eisenberg Glenn A (Chief Financial Officer, EVP) | Sale | 15,000 | 223.60 | 3,354,075 |
| 2024-08-08 | Anderson Kerrii B (Director) | Sale | 586 | 225.00 | 131,850 |
| 2024-08-07 | Anderson Kerrii B (Director) | Sale | 414 | 225.00 | 93,150 |
| 2024-08-05 | Berberian Lance (EVP, CIO & CTO) | Sale | 12,093 | 229.37 | 2,773,735 |
| 2024-06-06 | Rothman Paul (Director) | Option Ex | 717 | .00 | 0 |
| 2024-05-14 | Van Der Vaart Sandra D (EVP, Chief Legal Officer) | Sale | 2,000 | 210.83 | 421,662 |
| 2024-05-02 | Anderson Kerrii B (Director) | Sale | 250 | 200.10 | 50,024 |
| 2024-04-30 | Anderson Kerrii B (Director) | Sale | 250 | 204.13 | 51,033 |
| 2024-04-30 | Eisenberg Glenn A (Chief Financial Officer, EVP) | Option Ex | 10,229 | .00 | 0 |
| 2024-04-29 | Wilkinson Peter J (SVP, Chief Accounting Officer) | Sale | 2,439 | 204.33 | 498,358 |
| 2024-04-15 | Eisenberg Glenn A (Chief Financial Officer, EVP) | Option Ex | 10,229 | .00 | 0 |
| 2024-04-01 | Bailey Megan D. (EVP, Chief Strategy Officer) | Option Ex | 205 | .00 | 0 |
| 2024-04-01 | Summy Amy B. (EVP, Chief Marketing Officer) | Sale | 3,500 | 217.29 | 760,515 |
| 2024-04-01 | Schroeder Mark S (EVP, Pres Diagnostics & COO) | Sale | 6,477 | 217.29 | 1,407,387 |
| 2024-03-28 | Van Der Vaart Sandra D (EVP, Chief Legal Officer) | Sale | 3,553 | 216.74 | 770,077 |
| 2024-03-27 | Summy Amy B. (EVP, Chief Marketing Officer) | Option Ex | 5,778 | .00 | 0 |
| 2024-03-27 | Schroeder Mark S (EVP, Pres Diagnostics & COO) | Option Ex | 11,556 | .00 | 0 |
| 2024-03-27 | Caveney Brian J (EVP, Pres of ED, CMO & CSO) | Option Ex | 11,556 | .00 | 0 |
| 2024-03-27 | Van Der Vaart Sandra D (EVP, Chief Legal Officer) | Option Ex | 6,158 | .00 | 0 |
| 2024-03-27 | Divincenzo Jonathan P. (EVP, Pres, Central Labs & Intl) | Option Ex | 3,012 | .00 | 0 |
| 2024-03-27 | Wilkinson Peter J (SVP, Chief Accounting Officer) | Option Ex | 3,079 | .00 | 0 |
| 2024-03-27 | Schechter Adam H (President and CEO) | Option Ex | 72,435 | .00 | 0 |
| 2024-03-27 | Eisenberg Glenn A (Chief Financial Officer, EVP) | Option Ex | 20,033 | .00 | 0 |
| 2024-03-27 | Berberian Lance (EVP, CIO & CTO) | Option Ex | 7,697 | .00 | 0 |
| 2024-03-07 | Summy Amy B. (EVP, Chief Marketing Officer) | Sale | 227 | 218.45 | 49,588 |
| 2024-03-07 | Schroeder Mark S (EVP, Pres Diagnostics & COO) | Sale | 5,048 | 218.45 | 1,102,735 |
| 2024-03-07 | Schroeder Mark S (EVP, Pres Diagnostics & COO) | Option Ex | 2,119 | 117.09 | 248,113 |
| 2024-02-21 | Divincenzo Jonathan P. (EVP, Pres, Central Labs & Intl) | Sale | 500 | 215.49 | 107,745 |
| 2024-02-21 | Eisenberg Glenn A (Chief Financial Officer, EVP) | Sale | 34,504 | 216.64 | 7,474,843 |
| 2024-02-21 | Eisenberg Glenn A (Chief Financial Officer, EVP) | Option Ex | 14,054 | 163.63 | 2,299,656 |
| 2024-02-13 | Van Der Vaart Sandra D (EVP, Chief Legal Officer) | Sale | 237 | 226.45 | 53,668 |
| 2024-02-11 | Summy Amy B. (EVP, Chief Marketing Officer) | Option Ex | 201 | .00 | 0 |
| 2024-02-11 | Schroeder Mark S (EVP, Pres Diagnostics & COO) | Option Ex | 472 | .00 | 0 |
| 2024-02-11 | Caveney Brian J (EVP, Pres of ED, CMO & CSO) | Option Ex | 472 | .00 | 0 |
| 2024-02-11 | Van Der Vaart Sandra D (EVP, Chief Legal Officer) | Option Ex | 324 | .00 | 0 |
| 2024-02-11 | Divincenzo Jonathan P. (EVP, Pres, Central Labs & Intl) | Option Ex | 201 | .00 | 0 |
| 2024-02-11 | Wilkinson Peter J (SVP, Chief Accounting Officer) | Option Ex | 123 | .00 | 0 |
| 2024-02-11 | Schechter Adam H (President & CEO) | Option Ex | 2,964 | .00 | 0 |
| 2024-02-11 | Eisenberg Glenn A (Chief Financial Officer, EVP) | Option Ex | 807 | .00 | 0 |
| 2024-02-11 | Berberian Lance (EVP, CIO & CTO) | Option Ex | 324 | .00 | 0 |
| 2024-02-08 | Van Der Vaart Sandra D (EVP, Chief Legal Officer) | Sale | 259 | 222.06 | 57,513 |
| 2024-02-07 | Bailey Megan D. (EVP, Chief Strategy Officer) | Option Ex | 291 | .00 | 0 |
| 2024-02-07 | Kliphouse Kirsten Marie (Director) | Option Ex | 947 | .00 | 0 |
| 2024-02-07 | Summy Amy B. (EVP, Chief Marketing Officer) | Option Ex | 224 | .00 | 0 |
| 2024-02-07 | Schroeder Mark S (EVP, Pres Diagnostics & COO) | Option Ex | 680 | .00 | 0 |
| 2024-02-07 | Wengel Kathryn E (Director) | Option Ex | 947 | .00 | 0 |
| 2024-02-07 | Caveney Brian J (EVP, Pres of ED, CMO & CSO) | Option Ex | 629 | .00 | 0 |
| 2024-02-07 | Davis Jeffrey A. (Director) | Option Ex | 947 | .00 | 0 |
| 2024-02-07 | Gilliland Dwight Gary (Director) | Option Ex | 947 | .00 | 0 |
| 2024-02-07 | Parham Richelle P (Director) | Option Ex | 947 | .00 | 0 |
| 2024-02-07 | Van Der Vaart Sandra D (EVP, Chief Legal Officer) | Option Ex | 353 | .00 | 0 |
| 2024-02-07 | Divincenzo Jonathan P. (EVP, Pres, Central Labs & Intl) | Option Ex | 362 | .00 | 0 |
| 2024-02-07 | Kong Garheng (Director) | Option Ex | 947 | .00 | 0 |
| 2024-02-07 | Wilkinson Peter J (SVP, Chief Accounting Officer) | Option Ex | 134 | .00 | 0 |
| 2024-02-07 | Schechter Adam H (President & CEO) | Option Ex | 3,250 | .00 | 0 |
| 2024-02-07 | Williams R Sanders (Director) | Option Ex | 947 | .00 | 0 |
| 2024-02-07 | Neupert Peter M (Director) | Option Ex | 947 | .00 | 0 |
| 2024-02-07 | Anderson Kerrii B (Director) | Option Ex | 947 | .00 | 0 |
| 2024-02-07 | Eisenberg Glenn A (Chief Financial Officer, EVP) | Option Ex | 885 | .00 | 0 |
| 2024-02-07 | Graham Anita Z (EVP, CHRO) | Option Ex | 369 | .00 | 0 |
| 2024-02-07 | Belingard Jean-luc (Director) | Option Ex | 947 | .00 | 0 |
| 2024-02-07 | Berberian Lance (EVP, CIO & CTO) | Option Ex | 353 | .00 | 0 |
| 2024-02-05 | Van Der Vaart Sandra D (EVP, Chief Legal Officer) | Sale | 193 | 220.57 | 42,570 |
| 2024-02-02 | Summy Amy B. (EVP, Chief Marketing Officer) | Option Ex | 246 | .00 | 0 |
| 2024-02-02 | Schroeder Mark S (EVP, Pres Diagnostics & COO) | Option Ex | 495 | .00 | 0 |
| 2024-02-02 | Caveney Brian J (EVP, Pres of ED, CMO & CSO) | Option Ex | 495 | .00 | 0 |
| 2024-02-02 | Van Der Vaart Sandra D (EVP, Chief Legal Officer) | Option Ex | 264 | .00 | 0 |
| 2024-02-02 | Divincenzo Jonathan P. (EVP, Pres, Central Labs & Intl) | Option Ex | 246 | .00 | 0 |
| 2024-02-02 | Wilkinson Peter J (SVP, Chief Accounting Officer) | Option Ex | 131 | .00 | 0 |
| 2024-02-02 | Schechter Adam H (President & CEO) | Option Ex | 3,094 | .00 | 0 |
| 2024-02-02 | Eisenberg Glenn A (Chief Financial Officer, EVP) | Option Ex | 856 | .00 | 0 |
| 2024-02-02 | Berberian Lance (EVP, CIO & CTO) | Option Ex | 331 | .00 | 0 |
| 2023-12-15 | Divincenzo Jonathan P. (EVP, Pres, Central Labs & Intl) | Option Ex | 64 | .00 | 0 |
| 2023-11-16 | Wilkinson Peter J (SVP, Chief Accounting Officer) | Sale | 1,384 | 210.71 | 291,626 |
| 2023-10-12 | Kliphouse Kirsten Marie (Director) | Option Ex | 372 | .00 | 0 |
| 2023-08-08 | Anderson Kerrii B (Director) | Sale | 5,000 | 211.57 | 1,057,835 |
Insider trading activities including stock purchases, stock sales, and option exercises
of LH listed in the above tables cannot be completely guaranteed as to their accuracy.
For more insider trading information of Labcorp Holdings Inc. (symbol LH,
CIK number 920148) see
the Securities and Exchange Commission (SEC) website.